Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study.

Bonderup OK, Nielsen GL, Dall M, Pottegård A, Hallas J.

Aliment Pharmacol Ther. 2018 Jul 23. doi: 10.1111/apt.14916. [Epub ahead of print]

PMID:
30039564
2.

Qualitative exploration of practices to prevent medication errors in neonatal intensive care units: a focus group study.

Rishoej RM, Lai Nielsen H, Strzelec SM, Fritsdal Refer J, Allermann Beck S, Gramstrup HM, Thybo Christesen H, Juel Kjeldsen L, Hallas J, Almarsdóttir AB.

Ther Adv Drug Saf. 2018 Jul;9(7):343-353. doi: 10.1177/2042098618771541. Epub 2018 Apr 23.

3.

Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin.

Thrane JM, Støvring H, Hellfritzsch M, Hallas J, Pottegård A.

Pharmacoepidemiol Drug Saf. 2018 Jun 28. doi: 10.1002/pds.4581. [Epub ahead of print]

PMID:
29952049
4.

Using the "proportion of patients covered" and the Kaplan-Meier survival analysis to describe treatment persistence.

Rasmussen L, Pratt N, Hansen MR, Hallas J, Pottegård A.

Pharmacoepidemiol Drug Saf. 2018 Jun 27. doi: 10.1002/pds.4582. [Epub ahead of print]

PMID:
29952045
5.

Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark.

Pottegård A, Friis S, Verdoodt F, Dehlendorff C, Hallas J, Kjaer SK.

Acta Obstet Gynecol Scand. 2018 Jun 22. doi: 10.1111/aogs.13413. [Epub ahead of print]

PMID:
29932454
6.

Enough Power to Build a Strong Case for Clinical Pharmacy Services?-Reply.

Hallas J, Ravn-Nielsen LV, Pottegård A.

JAMA Intern Med. 2018 Jun 1;178(6):864-865. doi: 10.1001/jamainternmed.2018.1709. No abstract available.

PMID:
29868748
7.

Identifying signals of interest when screening for drug-outcome associations in health care data.

Pottegård A, Hallas J, Wang SV, Gagne JJ.

Br J Clin Pharmacol. 2018 Jun 3. doi: 10.1111/bcp.13634. [Epub ahead of print] No abstract available.

PMID:
29862551
8.

Treatment Failure of TNF-α Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.

Madsen KG, Pottegård A, Hallas J, Kjeldsen J.

Inflamm Bowel Dis. 2018 May 17. doi: 10.1093/ibd/izy178. [Epub ahead of print]

PMID:
29788214
9.

Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.

Aharaz A, Pottegård A, Henriksen DP, Hallas J, Beck-Nielsen H, Lassen AT.

PLoS One. 2018 May 8;13(5):e0196122. doi: 10.1371/journal.pone.0196122. eCollection 2018.

10.

Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study.

Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegård A, Berglind IA, Dedman D, Gutierrez L, Calingaert B, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S.

Drugs Real World Outcomes. 2018 May 7. doi: 10.1007/s40801-018-0133-1. [Epub ahead of print]

11.

Oral Immunosuppressive Treatment of Myasthenia Gravis in Denmark: A Nationwide Drug Utilization Study, 1996-2013.

Pedersen EG, Hallas J, Pottegård A, Hald SM, Jensen PEH, Gaist D.

Basic Clin Pharmacol Toxicol. 2018 May 6. doi: 10.1111/bcpt.13034. [Epub ahead of print]

PMID:
29732733
12.

External validity of a cardiovascular screening including a coronary artery calcium examination in middle-aged individuals from the general population.

Grønhøj MH, Gerke O, Mickley H, Steffensen FH, Lambrechtsen J, Sand NPR, Rasmussen LM, Olsen MH, Hallas J, Diederichsen AC.

Eur J Prev Cardiol. 2018 Jul;25(11):1156-1166. doi: 10.1177/2047487318774850. Epub 2018 May 3.

PMID:
29719966
13.

Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide study.

Ennis ZN, Broe A, Pottegård A, Ahern TP, Hallas J, Damkier P.

Br J Clin Pharmacol. 2018 Aug;84(8):1798-1805. doi: 10.1111/bcp.13614. Epub 2018 Jun 3.

PMID:
29688578
14.

Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model.

Joensen AM, Joergensen T, Lundbye-Christensen S, Johansen MB, Guzman-Castillo M, Bandosz P, Hallas J, Prescott EIB, Capewell S, O'Flaherty M.

PLoS One. 2018 Apr 19;13(4):e0194793. doi: 10.1371/journal.pone.0194793. eCollection 2018.

15.

Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations.

Hallas J, Wang SV, Gagne JJ, Schneeweiss S, Pratt N, Pottegård A.

Eur J Epidemiol. 2018 Jun;33(6):545-555. doi: 10.1007/s10654-018-0386-8. Epub 2018 Mar 31.

PMID:
29605890
16.

A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study).

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S.

Clin Epidemiol. 2018 Mar 13;10:299-310. doi: 10.2147/CLEP.S146442. eCollection 2018.

17.

Use of Dicloxacillin and Risk of Pregnancy among Users of Oral Contraceptives.

Pottegård A, Broe A, Stage TB, Brøsen K, Hallas J, Damkier P.

Basic Clin Pharmacol Toxicol. 2018 Mar 5. doi: 10.1111/bcpt.13000. [Epub ahead of print]

PMID:
29504695
18.

Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants.

Hellfritzsch M, Rasmussen L, Hallas J, Pottegård A.

Drug Saf. 2018 Jul;41(7):685-695. doi: 10.1007/s40264-018-0650-6.

PMID:
29498009
19.

Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians.

Rishoej RM, Hallas J, Juel Kjeldsen L, Thybo Christesen H, Almarsdóttir AB.

Ther Adv Drug Saf. 2018 Mar;9(3):179-192. doi: 10.1177/2042098617746053. Epub 2017 Dec 22.

20.

Association between use of phthalate-containing medication and semen quality among men in couples referred for assisted reproduction.

Broe A, Pottegård A, Hallas J, Ahern TP, Fedder J, Damkier P.

Hum Reprod. 2018 Feb 7. doi: 10.1093/humrep/dey009. [Epub ahead of print]

PMID:
29425332
21.

Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.

Wod M, Hallas J, Andersen K, García Rodríguez LA, Christensen K, Gaist D.

Clin Gastroenterol Hepatol. 2018 May;16(5):681-689. doi: 10.1016/j.cgh.2018.01.034. Epub 2018 Jan 31.

PMID:
29391266
22.

Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial.

Ravn-Nielsen LV, Duckert ML, Lund ML, Henriksen JP, Nielsen ML, Eriksen CS, Buck TC, Pottegård A, Hansen MR, Hallas J.

JAMA Intern Med. 2018 Mar 1;178(3):375-382. doi: 10.1001/jamainternmed.2017.8274.

PMID:
29379953
23.

Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.

Hallas J, Margulis AV, Pottegård A, Kristiansen NS, Atsma WJ, Appenteng K, de Vogel S, Kaye JA, Perez-Gutthann S, Arana A.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):612-619. doi: 10.1111/bcpt.12965. Epub 2018 Feb 22.

PMID:
29345103
24.

Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.

Pottegård A, Friis S, Stürmer T, Hallas J, Bahmanyar S.

Basic Clin Pharmacol Toxicol. 2018 May;122(5):451-459. doi: 10.1111/bcpt.12946. Epub 2018 Jan 15. Review.

25.

Disproportionality Analysis Used to Identify Patterns in Medication Error Reports Involving Hospitalized Children.

Rishoej RM, Thybo Christesen H, Juel Kjeldsen L, Almarsdóttir AB, Hallas J.

Basic Clin Pharmacol Toxicol. 2018 May;122(5):531-533. doi: 10.1111/bcpt.12947. Epub 2018 Jan 12. No abstract available.

PMID:
29265731
26.

Reply to M. Nayan et al.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2018 Feb 20;36(6):629-630. doi: 10.1200/JCO.2017.76.7186. Epub 2017 Dec 20. No abstract available.

PMID:
29261443
27.

Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study.

Reilev M, Damkier P, Rasmussen L, Olesen M, Thomsen Ernst M, Rishøj RM, Rix Hansen M, Broe A, Dastrup AS, Hellfritzsch M, Arnspang S, Pottegård A, Hallas J.

Therap Adv Gastroenterol. 2017 Dec;10(12):919-929. doi: 10.1177/1756283X17734116. Epub 2017 Oct 16.

28.

Conization and healthcare use: a population-based register study.

Frederiksen ME, Vázquez-Prada Baillet M, Jensen PT, Rygaard C, Hallas J, Lynge E.

Eur J Cancer Prev. 2017 Dec 11. doi: 10.1097/CEJ.0000000000000418. [Epub ahead of print]

PMID:
29194280
29.

Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution.

Laugesen K, Støvring H, Hallas J, Pottegård A, Jørgensen JOL, Sørensen HT, Petersen I.

Clin Epidemiol. 2017 Nov 16;9:591-600. doi: 10.2147/CLEP.S148671. eCollection 2017.

30.

Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study.

Margulis AV, Hallas J, Pottegård A, Kristiansen NS, Atsma WJ, Franks B, D'Silva M, Varas-Lorenzo C, Perez-Gutthann S, Arana A.

Eur J Clin Pharmacol. 2018 Feb;74(2):193-199. doi: 10.1007/s00228-017-2359-3. Epub 2017 Nov 13.

PMID:
29134254
31.

Aligning evidence: concerns regarding multiple sequence alignments in estimating the phylogeny of the Nudibranchia suborder Doridina.

Hallas JM, Chichvarkhin A, Gosliner TM.

R Soc Open Sci. 2017 Oct 25;4(10):171095. doi: 10.1098/rsos.171095. eCollection 2017 Oct.

32.

Using probability of drug use as independent variable in a register-based pharmacoepidemiological cause-effect study-An application of the reverse waiting time distribution.

Hallas J, Pottegård A, Støvring H.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1520-1526. doi: 10.1002/pds.4326. Epub 2017 Oct 12.

PMID:
29024218
33.

Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.

Rishoej RM, Almarsdóttir AB, Christesen HT, Hallas J, Kjeldsen LJ.

Eur J Pediatr. 2017 Dec;176(12):1697-1705. doi: 10.1007/s00431-017-3023-8. Epub 2017 Oct 1.

PMID:
28965285
34.

Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2017 Oct 10;35(29):3290-3297. doi: 10.1200/JCO.2016.71.8981. Epub 2017 Aug 14.

PMID:
28806117
35.

Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.

Simonsen JA, Mickley H, Johansen A, Hess S, Thomassen A, Gerke O, Jensen LO, Hallas J, Vach W, Hoilund-Carlsen PF.

BMJ Open. 2017 Aug 11;7(8):e016169. doi: 10.1136/bmjopen-2017-016169.

36.

Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.

Lai EC, Pratt N, Hsieh CY, Lin SJ, Pottegård A, Roughead EE, Kao Yang YH, Hallas J.

Eur J Epidemiol. 2017 Jul;32(7):567-582. doi: 10.1007/s10654-017-0281-8. Epub 2017 Jul 11. Review.

PMID:
28698923
37.

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation.

Hellfritzsch M, Grove EL, Husted SE, Rasmussen L, Poulsen BK, Johnsen SP, Hallas J, Pottegård A.

Europace. 2017 Jul 1;19(7):1091-1095. doi: 10.1093/europace/euw241.

38.

Montelukast use-a 19-year nationwide drug utilisation study.

Henriksen DP, Davidsen JR, Laursen CB, Christiansen A, Damkier P, Hallas J, Pottegård A.

Eur J Clin Pharmacol. 2017 Oct;73(10):1297-1304. doi: 10.1007/s00228-017-2286-3. Epub 2017 Jun 22.

PMID:
28639121
39.

Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial.

Bomme M, Hansen JM, Wildner-Christensen M, Hallas J, Schaffalitzky de Muckadell OB.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1715-1723.e7. doi: 10.1016/j.cgh.2017.06.006. Epub 2017 Jun 9.

PMID:
28606845
40.

External adjustment of unmeasured confounders in a case-control study of benzodiazepine use and cancer risk.

Thygesen LC, Pottegård A, Ersbøll AK, Friis S, Stürmer T, Hallas J.

Br J Clin Pharmacol. 2017 Nov;83(11):2517-2527. doi: 10.1111/bcp.13342. Epub 2017 Jul 12.

PMID:
28599067
41.

Inhaled Corticosteroids and Systemic or Topical Antifungal Therapy: A Symmetry Analysis.

Henriksen DP, Davidsen JR, Christiansen A, Laursen CB, Damkier P, Hallas J.

Ann Am Thorac Soc. 2017 Jun;14(6):1045-1047. doi: 10.1513/AnnalsATS.201612-1043LE. No abstract available.

PMID:
28570158
42.

The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding.

Laursen SB, Leontiadis GI, Stanley AJ, Hallas J, Schaffalitzky de Muckadell OB.

Aliment Pharmacol Ther. 2017 Aug;46(3):355-363. doi: 10.1111/apt.14153. Epub 2017 May 23.

PMID:
28543334
43.

Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.

Kristensen KL, Pottegård A, Hallas J, Rasmussen LM, Lindholt JS.

J Vasc Surg. 2017 Sep;66(3):768-774.e2. doi: 10.1016/j.jvs.2017.01.070. Epub 2017 May 12.

PMID:
28506478
44.

Ophthalmic nepafenac use in the Netherlands and Denmark.

Margulis AV, Houben E, Hallas J, Overbeek JA, Pottegård A, Torp-Pedersen T, Perez-Gutthann S, Arana A.

Acta Ophthalmol. 2017 Aug;95(5):509-517. doi: 10.1111/aos.13468. Epub 2017 May 10.

45.

Hydrochlorothiazide use is strongly associated with risk of lip cancer.

Pottegård A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD, Friis S.

J Intern Med. 2017 Oct;282(4):322-331. doi: 10.1111/joim.12629. Epub 2017 Jun 6.

PMID:
28480532
46.

Estimating medication stopping fraction and real-time prevalence of drug use in pharmaco-epidemiologic databases. An application of the reverse waiting time distribution.

Støvring H, Pottegård A, Hallas J.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):909-916. doi: 10.1002/pds.4217. Epub 2017 May 4.

PMID:
28474439
47.

Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.

Støvring H, Pottegård A, Hallas J.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):900-908. doi: 10.1002/pds.4216. Epub 2017 May 3.

PMID:
28466973
48.

Sidste kapitel om NSAID-bivirkninger er ikke skrevet endnu.

Hallas J.

Ugeskr Laeger. 2017 Feb 20;179(8). pii: V68865. Danish. No abstract available.

PMID:
28397658
49.

Population Exposure to Phthalate-containing Drugs.

Broe A, Ennis ZN, Pottegård A, Hallas J, Ahern T, Damkier P.

Basic Clin Pharmacol Toxicol. 2017 Sep;121(3):153-158. doi: 10.1111/bcpt.12781. Epub 2017 May 18.

PMID:
28371296
50.

Statins and polyneuropathy revisited: case-control study in Denmark, 1999-2013.

Svendsen TK, Nørregaard Hansen P, García Rodríguez LA, Andersen L, Hallas J, Sindrup SH, Gaist D.

Br J Clin Pharmacol. 2017 Sep;83(9):2087-2095. doi: 10.1111/bcp.13298. Epub 2017 May 11.

PMID:
28370351

Supplemental Content

Loading ...
Support Center